BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37203475)

  • 1. Fitness for Use of Anatomical Therapeutic Classification for Real World Data Research.
    Reinecke I; Henke E; Peng Y; Sedlmayr M; Bathelt F
    Stud Health Technol Inform; 2023 May; 302():711-715. PubMed ID: 37203475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A High-Fidelity Combined ATC-Rxnorm Drug Hierarchy for Large-Scale Observational Research.
    Ostropolets A; Talapova P; De Wilde M; Abedtash H; Rijnbeek P; Reich CG
    Stud Health Technol Inform; 2024 Jan; 310():53-57. PubMed ID: 38269764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and Challenges of Medical Procedure Data Harmonization to SNOMED-CT for Observational Research.
    Reinecke I; Kallfelz M; Sedlmayr M; Siebel J; Bathelt F
    Stud Health Technol Inform; 2022 May; 294():405-406. PubMed ID: 35612106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing Medical Vocabulary Updates in a Clinical Data Warehouse: An RxNorm Case Study.
    Podchiyska T; Hernandez P; Ferris T; Weber S; Lowe HJ
    AMIA Annu Symp Proc; 2010 Nov; 2010():477-81. PubMed ID: 21347024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards quality improvement of vaccine concept mappings in the OMOP vocabulary with a semi-automated method.
    Abeysinghe R; Black A; Kaduk D; Li Y; Reich C; Davydov A; Yao L; Cui L
    J Biomed Inform; 2022 Oct; 134():104162. PubMed ID: 36029954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication Reconciliation during Transitions of Care Across Institutions: A Quantitative Analysis of Challenges and Opportunities.
    Araya A; Thornton LR; Kwon D; Ferguson GM; Highfield LD; Hwang KO; Holmes HM; Bernstam EV
    Appl Clin Inform; 2023 Oct; 14(5):923-931. PubMed ID: 37726022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing U.S. prescription lists with RxNorm and the ATC/DDD Index.
    Bodenreider O; Rodriguez LM
    AMIA Annu Symp Proc; 2014; 2014():297-306. PubMed ID: 25954332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the variability of ingredient, strength, and dose form information from electronic prescriptions with RxNorm drug product descriptions.
    Lester CA; Flynn AJ; Marshall VD; Rochowiak S; Rowell B; Bagian JP
    J Am Med Inform Assoc; 2022 Aug; 29(9):1471-1479. PubMed ID: 35773948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to Supporting the Analysis of Historical Medication Datasets with RxNorm.
    Peters LB; Bodenreider O
    AMIA Annu Symp Proc; 2015; 2015():1034-41. PubMed ID: 26958241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the cohort selection performance of Australian Medicines Terminology to Anatomical Therapeutic Chemical mappings.
    Guo GN; Jonnagaddala J; Farshid S; Huser V; Reich C; Liaw ST
    J Am Med Inform Assoc; 2019 Nov; 26(11):1237-1246. PubMed ID: 31545380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing categorical information in two publicly available drug terminologies: RxNorm and NDF-RT.
    Pathak J; Chute CG
    J Am Med Inform Assoc; 2010; 17(4):432-9. PubMed ID: 20595311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of standard drug vocabularies in clinical research: a case study in pediatrics.
    Pathak J; Richesson RL
    AMIA Annu Symp Proc; 2010 Nov; 2010():607-11. PubMed ID: 21347050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts.
    Kawakami Y; Matsuda T; Hidaka N; Tanaka M; Kimura E
    J Am Med Inform Assoc; 2024 Jun; 31(7):1561-1568. PubMed ID: 38758661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enabling Hierarchical View of RxNorm with NDF-RT Drug Classes.
    Palchuk MB; Klumpenaar M; Jatkar T; Zottola RJ; Adams WG; Abend AH
    AMIA Annu Symp Proc; 2010 Nov; 2010():577-81. PubMed ID: 21347044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving standardized medication data in clinical research studies: two approaches and applications for implementing RxNorm.
    Richesson RL; Smith SB; Malloy J; Krischer JP
    J Med Syst; 2010 Aug; 34(4):651-7. PubMed ID: 20703919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and Improvement of Drug Data Structuredness From Electronic Health Records: Algorithm Development and Validation.
    Reinecke I; Siebel J; Fuhrmann S; Fischer A; Sedlmayr M; Weidner J; Bathelt F
    JMIR Med Inform; 2023 Jan; 11():e40312. PubMed ID: 36696159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized drug and pharmacological class network construction.
    Zhu Q; Jiang G; Wang L; Chute CG
    Stud Health Technol Inform; 2013; 192():1125. PubMed ID: 23920899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of RxNorm for Representing Ambulatory Prescriptions.
    O'Neill SM; Bell DS
    AMIA Annu Symp Proc; 2010 Nov; 2010():562-6. PubMed ID: 21347041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated mapping of pharmacy orders from two electronic health record systems to RxNorm within the STRIDE clinical data warehouse.
    Hernandez P; Podchiyska T; Weber S; Ferris T; Lowe H
    AMIA Annu Symp Proc; 2009 Nov; 2009():244-8. PubMed ID: 20351858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregations of Substance in Virtual Drug Models Based on ISO/CEN Standards for Identification of Medicinal Products (IDMP).
    Vander Stichele R; Kalra D
    Stud Health Technol Inform; 2022 May; 294():377-381. PubMed ID: 35612100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.